Oncologia

Estudo randomizado | Escore baseado em painel genético para avaliar o benefício da quimioterapia para o câncer de mama com nódulo positivo.

2 Dez, 2021 | 11:17h

21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer – New England Journal of Medicine (link para o resumo – $ para o texto completo)

Comentário no Twitter

Among postmenopausal women with HR–positive, HER2-negative breast cancer, 1-3 positive lymph nodes, and a 21-gene recurrence score of 25 or lower, 5-year invasive disease–free survival was similar whether they received endocrine or chemoendocrine therapy. https://t.co/aZLXBvSHHl pic.twitter.com/EBVnMkGHx4

— NEJM (@NEJM) December 2, 2021

Revisão | Tratamento atual e direções futuras na abordagem do câncer anal.

1 Dez, 2021 | 15:23h

Current treatment and future directions in the management of anal cancer – CA: A Cancer Journal for Clinicians

Oncologia integrativa | Direcionamento dos desafios globais de prevenção e tratamento de câncer.

1 Dez, 2021 | 15:22h

Integrative oncology: Addressing the global challenges of cancer prevention and treatment – Ca: A Cancer Journal for Clinicians

Comentário: Addressing the Global Challenges of Cancer Prevention and Treatment – The ASCO Post

M-A (maioria de estudos observacionais) | Comparação entre gastrojejunostomia e stent endoscópico para obstrução de esvaziamento gástrico.

30 Nov, 2021 | 12:14h

Comparison of gastrojejunostomy to endoscopic stenting for gastric outlet obstruction: An updated Systematic Review and Meta‐analysis – The American Journal of Surgery

Avanços na radioterapia para câncer de mama: implicações para as práticas atuais e futuras.

30 Nov, 2021 | 12:03h

Advances in Breast Cancer Radiotherapy: Implications for Current and Future Practice – JCO Oncology Practice

Comentário no Twitter

Advances in #BreastCancer radiotherapy allow shorter regimens and reduced toxicities. This #JCOOP Clinical review summarizes the latest evidence in #radonc for #bcsm @CshahMD ➡️ https://t.co/JxvU5FSQlv pic.twitter.com/GOcwAFJzRm

— Journal of Clinical Oncology (@JCO_ASCO) October 31, 2021

Diretriz CHEST | Rastreamento para câncer de pulmão.

29 Nov, 2021 | 10:56h

Resumo executivo: Screening for Lung Cancer: Chest Guideline and Expert Panel Report

Diretriz completa: Screening for Lung Cancer: CHEST Guideline and Expert Panel Report

Comunicado de imprensa: CHEST releases expert guidelines for lung cancer screening – Elsevier

Conteúdos relacionados:

USPSTF Statement: begin screening for lung cancer at age 50 years instead of 55 years for patients at risk

Meta-analysis: Lung cancer screening using low-dose computed tomography reduces lung cancer–specific mortality, albeit with a tradeoff of likely overdiagnosis

Comentário no Twitter

CHEST Guidelines and Expert Panel Report contains 16 evidence-based recommendations for the benefits, harms, and implementation of low-dose chest computed tomography (CT) screening. https://t.co/4mvjEOftQl #CHESTOnc #CHESTGuidelines #LungCancerAwarenessMonth pic.twitter.com/uyh9Pf0s5s

— CHEST® Journal (@journal_CHEST) November 23, 2021